Rhythm Biosciences (ASX:RHY) Price-to-Tangible-Book : 18.75 (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Price-to-Tangible-Book?

As of today (2024-05-16), Rhythm Biosciences's share price is A$0.075. Rhythm Biosciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.00. Hence, Rhythm Biosciences's Price to Tangible Book Ratio of today is 18.75.

The historical rank and industry rank for Rhythm Biosciences's Price-to-Tangible-Book or its related term are showing as below:

During the past 6 years, Rhythm Biosciences's highest Price to Tangible Book Ratio was 144.02. The lowest was 2.21. And the median was 16.72.

ASX:RHY's Price-to-Tangible-Book is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.57
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Rhythm Biosciences's share price is A$0.075. Rhythm Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.01. Hence, Rhythm Biosciences's P/B Ratio of today is 12.50.

Rhythm Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Rhythm Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Price-to-Tangible-Book Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.42

6.14

144.02

35.18

16.72

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial								65.98	35.18	25.51	16.72	33.04

Competitive Comparison of Rhythm Biosciences's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Rhythm Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's Price-to-Tangible-Book falls into.

Rhythm Biosciences Price-to-Tangible-Book Calculation

Rhythm Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.075	/	0.004
	=	18.75

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Rhythm Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (ASX:RHY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

0RY:Germany

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines